Back
Speaker illustration

Doctor Katrin Kemp Gudmundsdottir

Karolinska Institutet Danderyd Hospital, Stockholm (Sweden)

Member of:

European Society of Cardiology

Katrin studied medicine at Heidelberg University. She works as a clinical cardiologist, trained at Danderyd Hospital, Stockholm and is actively practicing part-time in Landspitali Hospital, Iceland. She is also currently CEO and practicing part-time in the private clinic Hjartamiðstöðin, Iceland. She defended her Ph.D at Karolinska Institute in 2020. Her research interests are focused on atrial fibrillation and the epidemiological aspects of screening. Katrin speaks Icelandic, German, Swedish and English fluently and is an avid traveller.

Presentations Articles

Ask the Trialist - STROKESTOP II

Event: ESC Congress 2024

Topic: Stroke Prevention

Session: Ask the Trialists from Hot Line 9

Access
Like
Thumbnail

STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds

Event: ESC Congress 2024

Topic: Stroke Prevention

Session: HOT LINE 9

Access
Like
Thumbnail

Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Cardiac biomarkers are here to stay

Access
Like
Thumbnail

NT-proBNP: a valuable marker to screen for Atrial Fibrillation.

Event: ESC Congress 2021 - The Digital Experience

Topic: Arrhythmias, General

Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients

Access
Like
Thumbnail

NT-proBNP: a valuable marker to screen for Atrial Fibrillation.

Event: ESC Congress 2021 - The Digital Experience

Topic: Arrhythmias, General

Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients

Access
Like
Thumbnail

Pulse palpation and history of palpitations in atrial fibrillation screening - preliminary results from the strokestop 2 study

Event: ESC Congress 2018

Topic: Diagnostic Methods

Session: Atrial fibrillation - Stroke prevention

Access
Like
Thumbnail

Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide - preliminary results from the strokestop 2 study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Detection, treatment, outcomes

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources